Bio-View Ltd (TLV:BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA 30.20
+0.80 (2.72%)
Feb 20, 2025, 2:28 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 37.85 million as of February 21, 2025. Its market cap has decreased by -14.27% in one year.
Market Cap
37.85M
Enterprise Value
23.86M
Revenue
34.34M
Ranking
n/a
PE Ratio
48.88
Stock Price
30.20
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 37.85M, a decrease of -36.70%. That is a compound annual growth rate of -2.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 69.16B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.57B |
| Bait Bakfar | 1.09B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |